NPS Pharma (NPSP) Reports Q3 Loss of $0.16, Misses by 4c
NPSP Hot Sheet
Revenue Growth %: -5.9%Financial Fact:
Income tax expense: 0
Today's EPS Names:
CMRG, LONG, IMOS, More
NPS Pharmaceuticals (NASDAQ: NPSP) reports Q3 loss of $0.16, 4 cents worse than the analyst estimate of ($0.12).
You May Also Be Interested In
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
- Zumiez, Inc. (ZUMZ) Tops Q1 EPS by 4c; Guides Q2 EPS Below Expectations
- Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c; Guides Q3 EPS
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
